Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,681,499
+$527,621 QoQ
Shares Held
12,065
+28.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Larson Financial Group LLC holds $47,576,049 across 18 Drug Manufacturers - General names. GILD ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,014 | $15,648,966 | |
| 2 | ABBV |
AbbVie Inc.
|
35,942 | $7,817,025 | |
| 3 | MRK |
Merck & Co., Inc.
|
59,707 | $7,182,155 | |
| 4 | JNJ |
Johnson & Johnson
|
28,428 | $6,948,940 | |
| 5 | PFE |
Pfizer Inc
|
109,981 | $3,088,266 | |
| 6 | AMGN |
Amgen Inc
|
6,334 | $2,228,617 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
33,017 | $2,002,481 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
12,065 | $1,681,499 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,681,499 | 12,065 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,153,878 | 9,401 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $922,743 | 8,313 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,460,379 | 13,172 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,285,885 | 11,476 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $850,265 | 9,205 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $656,886 | 7,835 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $299,894 | 4,371 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $109,362 | 1,493 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $98,589 | 1,217 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $89,853 | 1,199 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $80,384 | 1,043 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $79,568 | 959 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $96,323 | 1,122 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $54,842 | 889 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $51,240 | 829 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $48,392 | 814 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $58,451 | 805 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $61,747 | 884 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $72,027 | 1,046 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $57,197 | 885 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $41,189 | 707 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $44,106 | 698 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $53,550 | 696 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $58,537 | 783 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||